ATGE Stock Recent News
ATGE LATEST HEADLINES
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here is how Adtalem Global Education (ATGE) and CuriosityStream Inc. (CURI) have performed compared to their sector so far this year.
Adtalem (ATGE) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
ATGE has demonstrated robust revenue growth and strong profit margins over the past three years. ATGE's 3Q24 earnings showed year-over-year revenue growth of 11.8%, driven by growth in enrollment and tuition rates. The healthcare industry is facing significant labour shortages, which are expected to impact hospitals growth targets and outlook. ATGE plays a crucial role in training and providing healthcare professionals.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Adtalem's (ATGE) third-quarter fiscal 2024 results reflect benefits from initiatives and cost synergies.
Adtalem Global Education Inc. (NYSE:ATGE ) Q3 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants Jonathan Spitzer - Vice President, Investor Relations Steve Beard - President and Chief Executive Officer Bob Phelan - Chief Financial Officer Conference Call Participants Stephen Pollock - Robert W. Baird Alex Paris - Barrington Research Operator Greetings and welcome to the Adtalem Global Education Third Quarter Fiscal Year 2024 Earnings Call.
Adtalem's (ATGE) emphasis on cost-saving initiatives and strategic partnerships to drive long-term sustainability and growth.
Investors looking for stocks in the Schools sector might want to consider either Adtalem Global Education (ATGE) or Grand Canyon Education (LOPE). But which of these two stocks offers value investors a better bang for their buck right now?
Adtalem (ATGE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.